• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端肥大症患者胆囊息肉患病率增加。

Increased prevalence of gallbladder polyps in acromegaly.

机构信息

Institute of Metabolic ScienceAddenbrooke's Hospital, Cambridge University Hospitals National Health Service Foundation Trust, University of Cambridge, Addenbrooke's Hospital, CB2 0QQ Cambridge, United Kingdom.

出版信息

J Clin Endocrinol Metab. 2011 Jul;96(7):E1120-5. doi: 10.1210/jc.2010-2669. Epub 2011 May 4.

DOI:10.1210/jc.2010-2669
PMID:21543430
Abstract

INTRODUCTION

Several studies have suggested an increased prevalence of benign and malignant tumors in acromegaly, particularly colonic neoplasms. The gallbladder's epithelial similarity to the colon raises the possibility that gallbladder polyps (GBP) may occur more frequently in acromegaly.

PATIENTS AND METHODS

Thirty-one patients with newly diagnosed acromegaly (14 females, 17 males; mean age 54.7 yr, range 27-76 yr) were referred to our center between 2004 and 2008. All had pituitary adenomas and were treated with somatostatin analogs prior to transsphenoidal surgery. Biliary ultrasonography was performed at the time of referral. In a retrospective case-cohort study, we compared the prevalence of GBP in these scans with those of 13,234 consecutive patients (age range 20-80 yr) presenting at the hospital for abdominal/biliary ultrasound during the same time interval. Associations between GH and IGF-I levels and GBP in acromegaly were also examined.

RESULTS

There was a higher prevalence of GBP in patients with acromegaly compared with controls (29.03 vs 4.62%, P = 0.000008); relative risk was 6.29 (95% confidence interval 3.61-10.96). Eight of nine patients with acromegaly and GBP were older than 50 yr of age. GH levels were higher in those with GBP (median 30.8 μg/liter, interquartile range 10.9-39.1) than those without (8.2 μg/liter, interquartile range 6.0-16.0), but IGF-I levels were comparable.

CONCLUSIONS

This is the first study to demonstrate an increased prevalence of GBP in patients with newly diagnosed acromegaly. Further studies are required to determine whether these patients are at increased risk of developing gallbladder carcinoma and to define the role, if any, of biliary ultrasound surveillance.

摘要

简介

多项研究表明肢端肥大症患者中良性和恶性肿瘤的发病率增加,特别是结肠肿瘤。由于胆囊上皮与结肠相似,因此肢端肥大症患者胆囊息肉(GBP)的发生率可能更高。

患者和方法

2004 年至 2008 年间,我们中心共收治了 31 例新诊断的肢端肥大症患者(女性 14 例,男性 17 例;平均年龄 54.7 岁,范围 27-76 岁)。所有患者均患有垂体腺瘤,并在经蝶窦手术前接受了生长抑素类似物治疗。在转诊时进行了胆道超声检查。在一项回顾性病例对照研究中,我们比较了这些扫描中 GBP 的患病率与同期在医院因腹部/胆道超声就诊的 13234 例连续患者(年龄 20-80 岁)的患病率。还检查了肢端肥大症患者中 GH 和 IGF-I 水平与 GBP 之间的关系。

结果

与对照组相比,肢端肥大症患者的 GBP 患病率更高(29.03%比 4.62%,P=0.000008);相对风险为 6.29(95%置信区间 3.61-10.96)。肢端肥大症伴 GBP 的 9 例患者中有 8 例年龄大于 50 岁。与无 GBP 的患者相比(中位数 8.2μg/l,四分位间距 6.0-16.0),伴有 GBP 的患者的 GH 水平更高(中位数 30.8μg/l,四分位间距 10.9-39.1),但 IGF-I 水平相当。

结论

这是第一项证明新诊断的肢端肥大症患者 GBP 患病率增加的研究。需要进一步研究以确定这些患者是否有更高的患胆囊癌风险,并确定胆道超声监测的作用(如果有的话)。

相似文献

1
Increased prevalence of gallbladder polyps in acromegaly.肢端肥大症患者胆囊息肉患病率增加。
J Clin Endocrinol Metab. 2011 Jul;96(7):E1120-5. doi: 10.1210/jc.2010-2669. Epub 2011 May 4.
2
The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients.肢端肥大症患者空腹胰岛素浓度与结肠肿瘤的关联:一项基于结肠镜检查的对210例患者的研究
J Clin Endocrinol Metab. 2007 Oct;92(10):3854-60. doi: 10.1210/jc.2006-2551. Epub 2007 Jul 24.
3
Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up.生长激素分泌看似正常的肢端肥大症:对诊断和随访的意义
J Clin Endocrinol Metab. 2002 Aug;87(8):3537-42. doi: 10.1210/jcem.87.8.8658.
4
Identification of acromegalic patients at risk of developing colonic adenomas.识别有发生结肠腺瘤风险的肢端肥大症患者。
J Clin Endocrinol Metab. 2006 Apr;91(4):1351-6. doi: 10.1210/jc.2005-2500. Epub 2006 Jan 31.
5
[Outcome of somatostatin analogue treatment in acromegaly].[生长抑素类似物治疗肢端肥大症的疗效]
Orv Hetil. 2009 Aug 2;150(31):1457-62. doi: 10.1556/OH.2009.28688.
6
Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels.使用自体荧光结肠镜检查法检测肢端肥大症患者的结直肠病变及其与血清生长激素和胰岛素样生长因子-1水平的关系。
Neuro Endocrinol Lett. 2006 Oct;27(5):639-43.
7
Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly.36例肢端肥大症患者术后放疗的长期随访结果
J Clin Endocrinol Metab. 2000 Jul;85(7):2476-82. doi: 10.1210/jcem.85.7.6699.
8
Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.肢端肥大症的主要药物治疗:一项关于皮下和肌肉注射缓释奥曲肽对生长激素、胰岛素样生长因子-I及肿瘤大小影响的开放性、前瞻性、多中心研究
J Clin Endocrinol Metab. 2002 Oct;87(10):4554-63. doi: 10.1210/jc.2001-012012.
9
Octreotide as primary therapy for acromegaly.奥曲肽作为肢端肥大症的主要治疗方法。
J Clin Endocrinol Metab. 1998 Sep;83(9):3034-40. doi: 10.1210/jcem.83.9.5109.
10
Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels.肢端肥大症患者结直肠肿瘤的风险及其与血清生长激素水平的关系。
Am J Gastroenterol. 2005 May;100(5):1154-60. doi: 10.1111/j.1572-0241.2005.40808.x.

引用本文的文献

1
Biliary Tract Disorders and Associated Acute Complications in Patients With Acromegaly: A Single-Center Study.肢端肥大症患者的胆道疾病及相关急性并发症:一项单中心研究
J Clin Med Res. 2024 Apr;16(4):155-163. doi: 10.14740/jocmr5140. Epub 2024 Apr 30.
2
Growth hormone and gastrointestinal malignancy: An intriguing link.生长激素与胃肠道恶性肿瘤:一种有趣的联系。
World J Gastrointest Pathophysiol. 2023 Jan 22;14(1):1-11. doi: 10.4291/wjgp.v14.i1.1.
3
Gastrointestinal symptoms in acromegaly: A case control study.肢端肥大症的胃肠道症状:一项病例对照研究。
World J Gastrointest Pharmacol Ther. 2020 Jun 9;11(2):17-24. doi: 10.4292/wjgpt.v11.i2.17.
4
Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis.在 SODA 注册研究中纳入的患者中筛查合并症:一项为期 2 年的观察性分析。
Endocrine. 2018 Jul;61(1):105-117. doi: 10.1007/s12020-018-1615-3. Epub 2018 May 16.
5
Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly.肢端肥大症患者中E-钙黏蛋白、Slug和神经细胞黏附分子的表达及其与肿瘤侵袭性的关系。
Braz J Med Biol Res. 2017 Dec 11;51(2):e6808. doi: 10.1590/1414-431X20176808.
6
Modern perspectives on factors predisposing to the development of gallbladder cancer.胆囊癌发生相关因素的现代观点。
HPB (Oxford). 2013 Nov;15(11):839-44. doi: 10.1111/hpb.12046. Epub 2013 Jan 18.
7
The changing face of acromegaly--advances in diagnosis and treatment.肢端肥大症的变化面貌——诊断和治疗的进展。
Nat Rev Endocrinol. 2012 Oct;8(10):605-11. doi: 10.1038/nrendo.2012.101. Epub 2012 Jun 26.
8
Clinical manifestations and diagnosis of acromegaly.肢端肥大症的临床表现和诊断。
Int J Endocrinol. 2012;2012:540398. doi: 10.1155/2012/540398. Epub 2012 Feb 1.